86
Views
6
CrossRef citations to date
0
Altmetric
Review

Update on pulmonary hypertension complicating chronic obstructive pulmonary disease

&
Pages 351-363 | Published online: 08 Sep 2009

References

  • SimonneauGGalieNRubinLJClinical classification of pulmonary hypertensionJ Am Coll Cardiol20044312 Suppl5S12S15194173
  • RichSDantzkerDRAyresSMPrimary pulmonary hypertension. A national prospective studyAnn Intern Med198710722162233605900
  • McLaughlinVVArcherSLBadeschDBACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension AssociationCirculation2009119162250229419332472
  • Orozco-LeviMGarcia-AymerichJVillarJWood smoke exposure and risk of chronic obstructive pulmonary diseaseEur Respir J20062754254616507854
  • Global Initiative for Chronic Obstructive Lung DiseasePocket Guide to COPD Diagnosis, Management, and Prevention. A Guide for Health Care ProfessionalsGlobal Initiative for Chronic Obstructive Lung Disease; 2008
  • US Department of Health and Human services, National Institutes of Health, National Heart, Lung and Blood InstituteData Fact Sheet: Chronic Obstructive Pulmonary Disease NIH Publication Number 03–5229 March 2003. Available from: http://www.bipac.net/cqrc_test/NHLBI_COPD_FactSheet.pdf Accessed on August 22, 2009.
  • BuistASMcBurnieMAVollmerWMInternational variation in the prevalence of COPD (the BOLD Study): a population-based prevalence studyLancet2007370958974175017765523
  • MenezesAMPerez-PadillaRJardimJRChronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence studyLancet200536695001875188116310554
  • NaeijeRPulmonary hypertension and right heart failure in chronic obstructive pulmonary diseaseProc Am Thorac Soc200521202216113464
  • Oswald-MammosserMApprillMBachezPEhrhartMWeitzenblumEPulmonary hemodynamics in chronic obstructive pulmonary disease of the emphysematous typeRespiration19915856304310
  • ScharfSMIqbalMKellerCCrinerGLeeSFesslerHEHemodynamic characterization of patients with severe emphysemaAm J Respir Crit Care Med2002166331432212153963
  • ChaouatABugnetASKadaouiNSevere pulmonary hypertension and chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2005172218919415831842
  • ThabutGDauriatGSternGPulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantationChest200512751531153615888824
  • KesslerRFallerMWeitzenblumE“Natural history” of pulmonary hypertension in a series of 131 patients with chronic obstructive lung diseaseAm J Respir Crit Care Med2001164221922411463591
  • Moran-MendozaOPérez-PadillaJRSalazar-FloresMWood smoke-associated lung disease: a clinical, functional, radiological and pathological descriptionInt J Tuberc Lung Dis20081291092109818713510
  • BarberaJARiverolaARocaJPulmonary vascular abnormalities and ventilation-perfusion relationships in mild chronic obstructive pulmonary diseaseAm J Respir Crit Care Med1994149(2 Pt 1):4234298306040
  • McFarlanePAGardazJPSykesMKCO2 and mechanical factors reduce blood flow in a collapsed lung lobeJ Appl Physiol19845737397436436210
  • McGrathRLWeilJVAdverse effects of normovolemic polycythemia and hypoxia on hemodynamics in the dogCirc Res197843579379830544
  • HasegawaJWagnerKFKarpDAltered pulmonary vascular reactivity in mice with excessive erythrocytosisAm J Respir Crit Care Med2004169782983514701712
  • SekhonHSWrightJLChurgACigarette smoke causes rapid cell proliferation in small airways and associated pulmonary arteriesAm J Physiol1994267(5 Pt 1):L557L5637977766
  • HaleKAEwingSLGosnellBANiewoehnerDELung disease in long-term cigarette smokers with and without chronic air-flow obstructionAm Rev Respir Dis198413057167216497154
  • PeinadoVIBarberaJARamirezJEndothelial dysfunction in pulmonary arteries of patients with mild COPDAm J Physiol1998274(6 Pt 1):L908L9139609729
  • VoelkelNFTuderRMBridgesJArendWPInterleukin-1 receptor antagonist treatment reduces pulmonary hypertension generated in rats by monocrotalineAm J Respir Cell Mol Biol19941166646757946395
  • JoppaPPetrasovaDStancakBTkacovaRSystemic inflammation in patients with COPD and pulmonary hypertensionChest2006130232633316899829
  • ChaouatASavaleLChouaidCRole for interleukin-6 in COPD-related pulmonary hypertensionChest200946[Epub ahead of print].
  • EddahibiSChaouatAMorrellNPolymorphism of the serotonin transporter gene and pulmonary hypertension in chronic obstructive pulmonary diseaseCirculation2003108151839184414530202
  • NomuraSTandonNNNakamuraTConeJFukuharaSKambayashiJHigh-shear-stress-induced activation of platelets and microparticles enhances expression of cell adhesion molecules in THP-1 and endothelial cellsAtherosclerosis2001158227728711583705
  • ZhuZGLiHHZhangBRExpression of endothelin-1 and constitutional nitric oxide synthase messenger RNA in saphenous vein endothelial cells exposed to arterial flow shear stressAnn Thorac Surg1997645133313389386700
  • RabinovitchMKonstamMAGambleWJChanges in pulmonary blood flow affect vascular response to chronic hypoxia in ratsCirc Res19835244324416831659
  • StamlerJSLohERoddyMACurrieKECreagerMANitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humansCirculation1994895203520407514109
  • BarberaJAPeinadoVISantosSRamirezJRocaJRodriguez-RoisinRReduced expression of endothelial nitric oxide synthase in pulmonary arteries of smokersAm J Respir Crit Care Med2001164470971311520741
  • McGoonMGuttermanDSteenVScreening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelinesChest20041261 Suppl14S34S15249493
  • WeitzenblumEApprillMOswaldMChaouatAImbsJLPulmonary hemodynamics in patients with chronic obstructive pulmonary disease before and during an episode of peripheral edemaChest19941055137713828181323
  • FarberMOWeinbergerMHRobertsonGLFinebergNSManfrediFHormonal abnormalities affecting sodium and water balance in acute respiratory failure due to chronic obstructive lung diseaseChest198485149546690251
  • PedrinelliRDell’OmoGTaliniECanaleMLDi BelloVSystemic hypertension and the right-sided cardiovascular system: a review of the available evidenceJ Cardiovasc Med (Hagerstown)200910211512119377378
  • SajkovDDoug McEvoyRObstructive sleep apnea and pulmonary hypertensionProg Cardiovasc Dis200951536337019249442
  • MaiselASAtwoodJEGoldbergerALHepatojugular reflux: useful in the bedside diagnosis of tricuspid regurgitationAnn Intern Med198410167817826497192
  • TokudaYMiyagiSPhysical diagnosis of chronic obstructive pulmonary diseaseIntern Med200746231885189118057759
  • AhearnGSTapsonVFRebeizAGreenfieldJCJrElectrocardiography to define clinical status in primary pulmonary hypertension and pulmonary arterial hypertension secondary to collagen vascular diseaseChest2002122252452712171826
  • LupiEDumontCTejadaVMHorwitzSGallandFA radiologic index of pulmonary arterial hypertensionChest197568128311149525
  • LaabanJPDieboldBZelinskiRLafayMRaffoulHRochemaureJNoninvasive estimation of systolic pulmonary artery pressure using Doppler echocardiography in patients with chronic obstructive pulmonary diseaseChest1989966125812622582830
  • ArcasoySMChristieJDFerrariVAEchocardiographic assessment of pulmonary hypertension in patients with advanced lung diseaseAm J Respir Crit Care Med2003167573574012480614
  • HimelmanRBStulbargMKircherBNoninvasive evaluation of pulmonary artery pressure during exercise by saline-enhanced Doppler echocardiography in chronic pulmonary diseaseCirculation19897948638712924417
  • FisherMForfiaPChameraEAccuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertensionAm J Respir Crit Care Med200917961562119164700
  • OmmenSRNishimuraRAA clinical approach to the assessment of left ventricular diastolic function by Doppler echocardiography: update 2003Heart200389Suppl 3iii18iii2314594871
  • RaymondRJHinderliterALWillisPWEchocardiographic predictors of adverse outcomes in primary pulmonary hypertensionJ Am Coll Cardiol20023971214121911923049
  • EdwardsPDBullRKCouldenRCT measurement of main pulmonary artery diameterBr J Radiol1998718501018102010211060
  • LawlerLPCorlFMFishmanEKMulti-detector row and volume-rendered CT of the normal and accessory flow pathways of the thoracic systemic and pulmonary veinsRadiographics200222Spec No: S45S6012376600
  • LeySKreitnerKFFinkCHeusselCPBorstMMKauczorHUAssessment of pulmonary hypertension by CT and MR imagingEur Radiol200414335936814740163
  • ContractorSMaldjianPDSharmaVKGorDMRole of helical CT in detecting right ventricular dysfunction secondary to acute pulmonary embolismJ Comput Assist Tomogr200226458759112218825
  • TandriHDayaSKNasirKNormal reference values for the adult right ventricle by magnetic resonance imagingAm J Cardiol200698121660166417145230
  • GanCTHolverdaSMarcusJTRight ventricular diastolic dysfunction and the acute effects of sildenafil in pulmonary hypertension patientsChest20071321111717625080
  • OudkerkMvan BeekEJWielopolskiPComparison of contrast-enhanced magnetic resonance angiography and conventional pulmonary angiography for the diagnosis of pulmonary embolism: a prospective studyLancet200235993181643164712020524
  • SitbonOHumbertMJaisXLong-term response to calcium channel blockers in idiopathic pulmonary arterial hypertensionCirculation2005111233105311115939821
  • GemiciGErdimRCelikerAB-type natriuretic peptide levels in patients with COPD and normal right ventricular functionAdv Ther200825767468018563310
  • InoueYKawayamaTIwanagaThigh plasma brain natriuretic peptide levels in stable COPD without pulmonary hypertension or cor pulmonaleIntern Med200948750351219336951
  • BozkanatETozkoparanEBaysanODenizOCiftciFYokusogluMThe significance of elevated brain natriuretic peptide levels in chronic obstructive pulmonary diseaseJ Int Med Res200533553754416222887
  • WillemseBWPostmaDSTimensWten HackenNHThe impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammationEur Respir J20042346447615065840
  • GodtfredsenNLamTHanselTCOPD-related morbidity and mortality after smoking cessation: status of the evidenceEur Respir J20083284485318827152
  • Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Nocturnal Oxygen Therapy Trial GroupAnn Intern Med19809333913986776858
  • Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema Report of the Medical Research Council Working PartyLancet1981182226816866110912
  • BarberaJARogerNRocaJRoviraIHigenbottamTWRodriguez-RoisinRWorsening of pulmonary gas exchange with nitric oxide inhalation in chronic obstructive pulmonary diseaseLancet199634789994364408618485
  • BiernackiWFlenleyDCMuirALMacNeeWPulmonary hypertension and right ventricular function in patients with COPDChest1988946116911753191757
  • OlveySKRedutoLAStevensPMDeatonWJMillerRRFirst pass radionuclide assessment of right and left ventricular ejection fraction in chronic pulmonary disease. Effect of oxygen upon exercise responseChest1980781497471843
  • AshutoshKDunskyMNoninvasive tests for responsiveness of pulmonary hypertension to oxygen. Prediction of survival in patients with chronic obstructive lung disease and cor pulmonaleChest19879233933993622017
  • Oswald-MammosserMWeitzenblumEQuoixEPrognostic factors in COPD patients receiving long-term oxygen therapy. Importance of pulmonary artery pressureChest19951075119311987750305
  • ZielinskiJTobiaszMHawrylkiewiczISliwinskiPPalasiewiczGEffects of long-term oxygen therapy on pulmonary hemodynamics in COPD patients: a 6-year prospective studyChest1998113165709440570
  • AshutoshKPhadkeKJacksonJFSteeleDUse of nitric oxide inhalation in chronic obstructive pulmonary diseaseThorax200055210911310639526
  • VonbankKZiescheRHigenbottamTWControlled prospective randomised trial on the effects on pulmonary haemodynamics of the ambulatory long term use of nitric oxide and oxygen in patients with severe COPDThorax200358428929312668787
  • BaigorriFJosephDArtigasABlanchLInhaled nitric oxide does not improve cardiac or pulmonary function in patients with an exacerbation of chronic obstructive pulmonary diseaseCrit Care Med199927102153215810548198
  • ArcherSLMikeDCrowJLongWWeirEKA placebo-controlled trial of prostacyclin in acute respiratory failure in COPDChest199610937507558617086
  • SaadjianAPhilip-JoetFPaganelliFArnaudALevySLong-term effects of cicletanine on secondary pulmonary hypertensionJ Cardiovasc Pharmacol19983133643719514180
  • MaddenBPShethAWildeMOngYEDoes Sildenafil produce a sustained benefit in patients with pulmonary hypertension associated with parenchymal lung and cardiac diseaseVascul Pharmacol20074723184188
  • MaddenBPAllenbyMLokeTKShethAA potential role for sildenafil in the management of pulmonary hypertension in patients with parenchymal lung diseaseVascul Pharmacol200644537237616574495
  • AlpSSkryganMSchmidtWEBastianASildenafil improves hemodynamic parameters in COPD – an investigation of six patientsPulm Pharmacol Ther200619638639016291503
  • HolverdaSRietemaHBogaardHJAcute effects of sildenafil on exercise pulmonary hemodynamics and capacity in patients with COPDPulm Pharmacol Ther200821355856418342559
  • StolzDRaschHLinkaAA randomised, controlled trial of bosentan in severe COPDEur Respir J200832361962818448495
  • ValerioGBraccialePGrazia D’AgostinoAEffect of bosentan upon pulmonary hypertension in chronic obstructive pulmonary diseaseTher Adv Respir Dis200931152119293199